フローサイトメトリーの市場規模、シェア、動向分析レポート：製品別、技術別、最終用途別、地域別、セグメント別予測、2025年～2030年

フローサイトメトリー市場の成長と動向

Grand View Research, Inc.の最新レポートによると、世界のフローサイトメトリー市場規模は2030年までに70億1,310万米ドルに達すると推定され、2025～2030年のCAGRは8.41％で成長する見込みです。

技術の進歩により、Point-of-Care（PoC）検査用のマイクロ流体フローサイトメトリーの開発など、新しく改良された分析ツールが導入されています。さらに、がん、免疫不全症、感染症の有病率の上昇が産業を牽引しています。さらに、バイオ医薬品、ライフサイエンス、バイオテクノロジーの研究活動における研究開発投資の増加が、フローサイトメトリー機器の高い需要につながっています。最近の動向では、PoC検査用の携帯型マイクロ流体フローサイトメトリー機器の開発に主要焦点が当てられています。

マイクロフルイディクスとフローサイトメトリーを組み合わせることで、生物学的サンプルの複数の特性を測定する有用なツールとなります。例えば、いくつかのマイクロ流体や小型化された検出器が容易に入手できるようになったことで、オプトフルイディックサイトメーター、イメージングサイトメーター、インピーダンスサイトメーターなどのマイクロチップを用いたサイトメーターの開発が可能になりました。マイクロ流体フローサイトメトリー機器の開発は、費用対効果が高く、持ち運びが可能でコンパクトであり、有益です。これらはアジアやアフリカなどの新興経済諸国では手頃な価格で入手可能であり、PoC検査アプリケーションの急速な成長を可能にしています。さらに、蛍光色素の改良と学術研究環境におけるベンチトップサイトメーターの有用性の増加が、産業を牽引すると予想されます。

マルチカラーフローサイトメトリーの開発により、新薬開発活動におけるこの技術の採用が加速しています。例えば、2020年1月、ベックマン・コールター・ライフサイエンシズから13色の臨床用フローサイトメトリーシステムであるDxFLEX、CE-IVDが欧州で発売されました。同様に、複数のパラメーターの同時評価による簡便な細胞分析により、このような機器は受託研究目的で広く使用されています。COVID-19の大流行も、このセグメントの新製品の発売によって証明されているように、技術の革新に拍車をかけた。例えば、2021年7月、Metropolis Healthcare Ltd.は、COVID-19入院患者のリスク状態を検出する簡単な血液検査であるCoviRisk-TBNKを発売しました。

この検査は、ICUへの入室や人工呼吸の必要性を分析し、医療資源への負担を軽減するのに役立ちます。この検査はフローサイトメトリーベースのリンパ球サブセットアッセイで、体外診断用医薬品の承認を受けています。このような技術革新は近い将来、産業の成長を促進すると予想されます。さらに、フローサイトメトリーは免疫細胞をリストアップし、その特徴を明らかにする重要なツールであり、根本的な遺伝的欠陥の認識と検証にも役立ちます。この技術は、幹細胞移植後の患者の免疫反応を観察・モニターするためにも使用されるため、臓器移植は産業の成長を後押しする重要な役割を担っています。WHOによると、世界では毎年約5万件の幹細胞移植が行われており、この数は将来の展望を広げ、この技術の応用範囲を広げると予想されています。

その一方で、機器は非常に高価であるため、発展途上諸国では、技術的に先進的フローサイトメトリー機器を購入する余裕がない可能性があります。これらの機器は10万米ドル以上することもあり、中小規模の病院や臨床検査室にとっては予算的に大きな制約となります。しかし、Sonyのような一部のメーカーは、多くのプロセスを自動化するソフトウェアを使用した、より新しい機器を発売しようとしています。このような開発は、技術の使い勝手を向上させるだけでなく、近い将来、平均機器コスト（10万米ドル以下）を引き下げるのに役立つと考えられます。

フローサイトメトリー市場レポートハイライト

• 2024年には、技術開拓による普及率の向上により、機器部門が35.30%の最大売上シェアで市場をリードしています。
• 技術別では、細胞ベースセグメントが2024年に76.16%の最大売上シェアで市場をリードしています。
• 用途別では、臨床セグメントが2024年に45.34％の最大売上シェアで市場をリードしました。
• 最終用途別では、学術機関セグメントが2024年に最大の収益シェアを占め、これは細胞生物学と分子診断におけるフローサイトメトリーの広範な使用によるものです。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 フローサイトメトリー市場の変数、動向、範囲

• 市場イントロダクション/系統展望
• 市場規模と成長展望
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• フローサイトメトリー市場分析ツール
  • ポーター分析
  • PESTEL分析

第4章 フローサイトメトリー市場：製品別、推定・動向分析

• フローサイトメトリー市場：製品変動分析
• フローサイトメトリー市場：製品変動分析、100万米ドル、2024年と2030年
• 機器
  • 細胞分析機器
  • 細胞選別機器
• 試薬と消耗品
• ソフトウェア
• 付属品
• サービス

第5章 フローサイトメトリー市場：技術別、推定・動向分析

• フローサイトメトリー市場：技術変動分析
• フローサイトメトリー市場：技術変動分析、100万米ドル、2024年と2030年
• 細胞ベース
• ビーズベース

第6章 フローサイトメトリー市場：用途別、推定・動向分析

• フローサイトメトリー市場：用途変動分析
• フローサイトメトリー市場：用途変動分析、100万米ドル、2024年と2030年
• 研究
  • 医薬品
  • 薬剤アポトーシス
  • 細胞選別
  • 細胞周期分析
  • 免疫学
  • 細胞生存率
• 産業
• 臨床
  • がん
  • 臓器移植
  • 免疫不全
  • 血液学
  • 自己免疫疾患

第7章 フローサイトメトリー市場：最終用途別、推定・動向分析

• フローサイトメトリー市場：最終用途変動分析
• フローサイトメトリー市場：最終用途変動分析、100万米ドル、2024年と2030年
• 臨床検査ラボ
• 学術機関
• 商業組織
  • バイオテクノロジー企業
  • 製薬会社
  • CRO
• 病院

第8章 フローサイトメトリー市場：地域別、推定・動向分析

• フローサイトメトリー市場シェア、地域別、2024年と2030年、100万米ドル
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • デンマーク
  • スウェーデン
  • ノルウェー
• アジア太平洋
  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
  • タイ
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第9章 競合情勢

• 主要市場参入企業による最近の動向と影響分析
• 企業分類
• 企業ヒートマップ分析
• 企業プロファイル
  • Danaher
  • BD
  • Sysmex Corporation
  • Apogee Flow Systems Ltd.
  • Bio-Rad Laboratories, Inc.
  • Thermo Fisher Scientific, Inc.
  • Stratedigm, Inc.
  • Miltenyi BIoTec
  • Cytek Biosciences
  • Sony Group Corporation（Sony BIoTechnology Inc.）

List of Tables

• Table 1 List of secondary sources
• Table 2 Regulatory status and recommended validation strategy for flow cytometry assays
• Table 3 CPT codes for flow cytometry reimbursement
• Table 4 Global flow cytometry market, by product, 2018 - 2030 (USD Million)
• Table 5 Global flow cytometry market, by technology, 2018 - 2030 (USD Million)
• Table 6 Global flow cytometry market, application, 2018 - 2030 (USD Million)
• Table 7 Global flow cytometry market, end-use, 2018 - 2030 (USD Million)
• Table 8 Global flow cytometry market, by region, 2018 - 2030 (USD Million)
• Table 9 North America flow cytometry market, by country, 2018 - 2030 (USD Million)
• Table 10 North America flow cytometry market, by product, 2018 - 2030 (USD Million)
• Table 11 North America flow cytometry market, by technology, 2018 - 2030 (USD Million)
• Table 12 North America flow cytometry market, application, 2018 - 2030 (USD Million)
• Table 13 North America flow cytometry market, end-use, 2018 - 2030 (USD Million)
• Table 14 U.S. Flow cytometry market, by product, 2018 - 2030 (USD Million)
• Table 15 U.S. Flow cytometry market, by technology, 2018 - 2030 (USD Million)
• Table 16 U.S. Flow cytometry market, application, 2018 - 2030 (USD Million)
• Table 17 U.S. Flow cytometry market, end-use, 2018 - 2030 (USD Million)
• Table 18 Canada flow cytometry market, by product, 2018 - 2030 (USD Million)
• Table 19 Canada flow cytometry market, by technology, 2018 - 2030 (USD Million)
• Table 20 Canada flow cytometry market, application, 2018 - 2030 (USD Million)
• Table 21 Canada flow cytometry market, end-use, 2018 - 2030 (USD Million)
• Table 22 Mexico flow cytometry market, by product, 2018 - 2030 (USD Million)
• Table 23 Mexico flow cytometry market, by technology, 2018 - 2030 (USD Million)
• Table 24 Mexico flow cytometry market, application, 2018 - 2030 (USD Million)
• Table 25 Mexico flow cytometry market, end-use, 2018 - 2030 (USD Million)
• Table 26 Europe flow cytometry market, by country, 2018 - 2030 (USD Million)
• Table 27 Europe flow cytometry market, by product, 2018 - 2030 (USD Million)
• Table 28 Europe flow cytometry market, by technology, 2018 - 2030 (USD Million)
• Table 29 Europe flow cytometry market, application, 2018 - 2030 (USD Million)
• Table 30 Europe flow cytometry market, end-use, 2018 - 2030 (USD Million)
• Table 31 Germany flow cytometry market, by product, 2018 - 2030 (USD Million)
• Table 32 Germany flow cytometry market, by technology, 2018 - 2030 (USD Million)
• Table 33 Germany flow cytometry market, application, 2018 - 2030 (USD Million)
• Table 34 Germany flow cytometry market, end-use, 2018 - 2030 (USD Million)
• Table 35 UK flow cytometry market, by product, 2018 - 2030 (USD Million)
• Table 36 UK flow cytometry market, by technology, 2018 - 2030 (USD Million)
• Table 37 UK flow cytometry market, application, 2018 - 2030 (USD Million)
• Table 38 UK flow cytometry market, end-use, 2018 - 2030 (USD Million)
• Table 39 France flow cytometry market, by product, 2018 - 2030 (USD Million)
• Table 40 France flow cytometry market, by technology, 2018 - 2030 (USD Million)
• Table 41 France flow cytometry market, application, 2018 - 2030 (USD Million)
• Table 42 France flow cytometry market, end-use, 2018 - 2030 (USD Million)
• Table 43 Italy flow cytometry market, by product, 2018 - 2030 (USD Million)
• Table 44 Italy flow cytometry market, by technology, 2018 - 2030 (USD Million)
• Table 45 Italy flow cytometry market, application, 2018 - 2030 (USD Million)
• Table 46 Italy flow cytometry market, end-use, 2018 - 2030 (USD Million)
• Table 47 Spain flow cytometry market, by product, 2018 - 2030 (USD Million)
• Table 48 Spain flow cytometry market, by technology, 2018 - 2030 (USD Million)
• Table 49 Spain flow cytometry market, application, 2018 - 2030 (USD Million)
• Table 50 Spain flow cytometry market, end-use, 2018 - 2030 (USD Million)
• Table 51 Denmark flow cytometry market, by product, 2018 - 2030 (USD Million)
• Table 52 Denmark flow cytometry market, by technology, 2018 - 2030 (USD Million)
• Table 53 Denmark flow cytometry market, application, 2018 - 2030 (USD Million)
• Table 54 Denmark flow cytometry market, end-use, 2018 - 2030 (USD Million)
• Table 55 Sweden flow cytometry market, by product, 2018 - 2030 (USD Million)
• Table 56 Sweden flow cytometry market, by technology, 2018 - 2030 (USD Million)
• Table 57 Sweden flow cytometry market, application, 2018 - 2030 (USD Million)
• Table 58 Sweden flow cytometry market, end-use, 2018 - 2030 (USD Million)
• Table 59 Norway flow cytometry market, by product, 2018 - 2030 (USD Million)
• Table 60 Norway flow cytometry market, by technology, 2018 - 2030 (USD Million)
• Table 61 Norway flow cytometry market, application, 2018 - 2030 (USD Million)
• Table 62 Norway flow cytometry market, end-use, 2018 - 2030 (USD Million)
• Table 63 Asia pacific flow cytometry market, by country, 2018 - 2030 (USD Million)
• Table 64 Asia pacific flow cytometry market, by product, 2018 - 2030 (USD Million)
• Table 65 Asia pacific flow cytometry market, by technology, 2018 - 2030 (USD Million)
• Table 66 Asia pacific flow cytometry market, application, 2018 - 2030 (USD Million)
• Table 67 Asia pacific flow cytometry market, end-use, 2018 - 2030 (USD Million)
• Table 68 China flow cytometry market, by product, 2018 - 2030 (USD Million)
• Table 69 China flow cytometry market, by technology, 2018 - 2030 (USD Million)
• Table 70 China flow cytometry market, application, 2018 - 2030 (USD Million)
• Table 71 China flow cytometry market, end-use, 2018 - 2030 (USD Million)
• Table 72 India flow cytometry market, by product, 2018 - 2030 (USD Million)
• Table 73 India flow cytometry market, by technology, 2018 - 2030 (USD Million)
• Table 74 India flow cytometry market, application, 2018 - 2030 (USD Million)
• Table 75 India flow cytometry market, end-use, 2018 - 2030 (USD Million)
• Table 76 Japan flow cytometry market, by product, 2018 - 2030 (USD Million)
• Table 77 Japan flow cytometry market, by technology, 2018 - 2030 (USD Million)
• Table 78 Japan flow cytometry market, application, 2018 - 2030 (USD Million)
• Table 79 Japan flow cytometry market, end-use, 2018 - 2030 (USD Million)
• Table 80 South Korea flow cytometry market, by product, 2018 - 2030 (USD Million)
• Table 81 South Korea flow cytometry market, by technology, 2018 - 2030 (USD Million)
• Table 82 South Korea flow cytometry market, application, 2018 - 2030 (USD Million)
• Table 83 South Korea flow cytometry market, end-use, 2018 - 2030 (USD Million)
• Table 84 Australia flow cytometry market, by product, 2018 - 2030 (USD Million)
• Table 85 Australia flow cytometry market, by technology, 2018 - 2030 (USD Million)
• Table 86 Australia flow cytometry market, application, 2018 - 2030 (USD Million)
• Table 87 Australia flow cytometry market, end-use, 2018 - 2030 (USD Million)
• Table 88 Thailand flow cytometry market, by product, 2018 - 2030 (USD Million)
• Table 89 Thailand flow cytometry market, by technology, 2018 - 2030 (USD Million)
• Table 90 Thailand flow cytometry market, application, 2018 - 2030 (USD Million)
• Table 91 Thailand flow cytometry market, end-use, 2018 - 2030 (USD Million)
• Table 92 Latin America flow cytometry market, by country, 2018 - 2030 (USD Million)
• Table 93 Latin America flow cytometry market, by product, 2018 - 2030 (USD Million)
• Table 94 Latin America flow cytometry market, by technology, 2018 - 2030 (USD Million)
• Table 95 Latin America flow cytometry market, application, 2018 - 2030 (USD Million)
• Table 96 Latin America flow cytometry market, end-use, 2018 - 2030 (USD Million)
• Table 97 Brazil flow cytometry market, by product, 2018 - 2030 (USD Million)
• Table 98 Brazil flow cytometry market, by technology, 2018 - 2030 (USD Million)
• Table 99 Brazil flow cytometry market, application, 2018 - 2030 (USD Million)
• Table 100 Brazil flow cytometry market, end-use, 2018 - 2030 (USD Million)
• Table 101 Argentina flow cytometry market, by product, 2018 - 2030 (USD Million)
• Table 102 Argentina flow cytometry market, by technology, 2018 - 2030 (USD Million)
• Table 103 Argentina flow cytometry market, application, 2018 - 2030 (USD Million)
• Table 104 Argentina flow cytometry market, end-use, 2018 - 2030 (USD Million)
• Table 105 Middle east & Africa flow cytometry market, by country, 2018 - 2030 (USD Million)
• Table 106 Middle east & Africa flow cytometry market, by product, 2018 - 2030 (USD Million)
• Table 107 Middle east & Africa flow cytometry market, by technology, 2018 - 2030 (USD Million)
• Table 108 Middle east & Africa flow cytometry market, application, 2018 - 2030 (USD Million)
• Table 109 Middle east & Africa flow cytometry market, end-use, 2018 - 2030 (USD Million)
• Table 110 South Africa flow cytometry market, by product, 2018 - 2030 (USD Million)
• Table 111 South Africa flow cytometry market, by technology, 2018 - 2030 (USD Million)
• Table 112 South Africa flow cytometry market, application, 2018 - 2030 (USD Million)
• Table 113 South Africa flow cytometry market, end-use, 2018 - 2030 (USD Million)
• Table 114 Saudi Arabia flow cytometry market, by product, 2018 - 2030 (USD Million)
• Table 115 Saudi Arabia flow cytometry market, by technology, 2018 - 2030 (USD Million)
• Table 116 Saudi Arabia flow cytometry market, application, 2018 - 2030 (USD Million)
• Table 117 Saudi Arabia flow cytometry market, end-use, 2018 - 2030 (USD Million)
• Table 118 UAE flow cytometry market, by product, 2018 - 2030 (USD Million)
• Table 119 UAE flow cytometry market, by technology, 2018 - 2030 (USD Million)
• Table 120 UAE flow cytometry market, application, 2018 - 2030 (USD Million)
• Table 121 UAE flow cytometry market, end-use, 2018 - 2030 (USD Million)
• Table 122 Kuwait flow cytometry market, by product, 2018 - 2030 (USD Million)
• Table 123 Kuwait flow cytometry market, by technology, 2018 - 2030 (USD Million)
• Table 124 Kuwait flow cytometry market, application, 2018 - 2030 (USD Million)
• Table 125 Kuwait flow cytometry market, end-use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Primary research pattern
• Fig. 4 Market research approaches
• Fig. 5 Value-chain-based sizing & forecasting
• Fig. 6 Value-chain-based sizing & forecasting
• Fig. 7 QFD modeling for market share assessment
• Fig. 8 Market formulation & validation
• Fig. 9 Commodity flow analysis
• Fig. 10 Volume price analysis
• Fig. 11 Market snapshot
• Fig. 12 Segment snapshot
• Fig. 13 Competitive landscape snapshot
• Fig. 14 Parent market outlook (2024)
• Fig. 15 Flow cytometry market driver impact
• Fig. 16 Flow cytometry market restraint impact
• Fig. 17 Porter's five force analysis
• Fig. 18 SWOT analysis, by factor (political & legal, economic and technological)
• Fig. 19 Flow cytometry market: product outlook & key takeaways
• Fig. 20 Flow cytometry market: product movement analysis
• Fig. 21 Global instruments market, 2018 - 2030 (USD Million)
• Fig. 22 Global cell analyzers market, 2018 - 2030 (USD Million)
• Fig. 23 Global cell sorters market, 2018 - 2030 (USD Million)
• Fig. 24 Global reagents & consumables market, 2018 - 2030 (USD Million)
• Fig. 25 Global software market, 2018 - 2030 (USD Million)
• Fig. 26 Global accessories market, 2018 - 2030 (USD Million)
• Fig. 27 Global services market, 2018 - 2030 (USD Million)
• Fig. 28 Flow cytometry market: technology outlook & key takeaways
• Fig. 29 Flow cytometry market: technology movement analysis
• Fig. 30 Global cell-based market, 2018 - 2030 (USD Million)
• Fig. 31 Global bead-based market, 2018 - 2030 (USD Million)
• Fig. 32 Flow cytometry market: application outlook & key takeaways
• Fig. 33 Flow cytometry market: application movement analysis
• Fig. 34 Global research application market, 2018 - 2030 (USD Million)
• Fig. 35 Global pharmaceutical application market, 2018 - 2030 (USD Million)
• Fig. 36 Global drug discovery application market, 2018 - 2030 (USD Million)
• Fig. 37 Global in vitro toxicity application market, 2018 - 2030 (USD Million)
• Fig. 38 Global stem cell application market, 2018 - 2030 (USD Million)
• Fig. 39 Global apoptosis application market, 2018 - 2030 (USD Million)
• Fig. 40 Global cell sorting application market, 2018 - 2030 (USD Million)
• Fig. 41 Global cell cycle analysis application market, 2018 - 2030 (USD Million)
• Fig. 42 Global immunology application market, 2018 - 2030 (USD Million)
• Fig. 43 Global cell viability application market, 2018 - 2030 (USD Million)
• Fig. 44 Global other applications market, 2018 - 2030 (USD Million)
• Fig. 45 Global industrial application market, 2018 - 2030 (USD Million)
• Fig. 46 Global clinical application market, 2018 - 2030 (USD Million)
• Fig. 47 Global cancer application market, 2018 - 2030 (USD Million)
• Fig. 48 Global organ transplantation application market, 2018 - 2030 (USD Million)
• Fig. 49 Global immunodeficiency application market, 2018 - 2030 (USD Million)
• Fig. 50 Global hematology application market, 2018 - 2030 (USD Million)
• Fig. 51 Global autoimmune disorders market, 2018 - 2030 (USD Million)
• Fig. 52 Flow cytometry market: end use outlook & key takeaways
• Fig. 53 Flow cytometry market: end use movement analysis
• Fig. 54 Global commercial organizations market, 2018 - 2030 (USD Million)
• Fig. 55 Global biotechnology companies market, 2018 - 2030 (USD Million)
• Fig. 56 Global pharmaceutical companies market, 2018 - 2030 (USD Million)
• Fig. 57 Global CROs market, 2018 - 2030 (USD Million)
• Fig. 58 Global hospitals market, 2018 - 2030 (USD Million)
• Fig. 59 Global academic institutes market, 2018 - 2030 (USD Million)
• Fig. 60 Global clinical testing labs market, 2018 - 2030 (USD Million)
• Fig. 61 Regional marketplace: key takeaway
• Fig. 62 Flow cytometry market: regional movement analysis
• Fig. 63 North America market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 64 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 65 Canada market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 66 Europe market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 67 Germany market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 68 UK market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 69 France market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 70 Italy market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 71 Spain market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 72 Denmark market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 73 Sweden market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 74 Norway market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 75 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 76 Japan market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 77 China market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 78 India market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 79 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 80 Australia market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 81 Singapore market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 82 Thailand market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 83 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 84 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 85 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 86 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 87 Middle East and Africa market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 88 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 89 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 90 UAE market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 91 Kuwait market estimates and forecast, 2018 - 2030 (USD Million)

Flow Cytometry Market Growth & Trends:

The global flow cytometry market size is estimated to reach USD 7,013.1 million by 2030, registering to grow at a CAGR of 8.41% from 2025 to 2030 according to a new report by Grand View Research, Inc. Technological advancements in the technique are introducing new and improved analytical tools, which include the development of microfluidic flow cytometry for Point-of-Care (PoC) testing. Furthermore, the rising prevalence of cancer, immunodeficiency disorders, and infectious diseases is driving the industry. In addition, increasing R&D investments in biopharmaceutical, life science, and biotechnology research activities have led to high demand for flow cytometry instruments. In recent years, a key focus has been on the development of portable microfluidic flow cytometry devices for PoC testing.

Microfluidics and flow cytometry together make a useful tool to measure multiple characteristics of biological samples. For instance, the easy availability of several microfluidics and miniaturized detectors have enabled the creation of microchip-based cytometers, such as optofluidic cytometer, imaging cytometer, and impedance cytometer. The development of microfluidic flow cytometry devices, which are cost-effective, portable, and compact, is beneficial. They are affordable in developing economies, such as Asia & Africa, and are enabling rapid growth in PoC testing applications. Furthermore, improvements in fluorescent dyes and the increasing utility of benchtop cytometers for academic research settings are expected to drive the industry.

Developments in multicolor flow cytometry are accelerating the adoption of the technique in novel drug development activities. For instance, in January 2020, DxFLEX, CE-IVD, a 13-colour clinical flow cytometry system was launched by Beckman Coulter Life Sciences in Europe. Similarly, easy cellular analysis by simultaneous evaluation of several parameters allows extensive use of such devices for contract research purposes. The COVID-19 pandemic also spurred innovations in the technique, as evidenced by the launch of new products in this domain. For instance, in July 2021, Metropolis Healthcare Ltd. launched CoviRisk-TBNK, a simple blood test to detect the risk status of a COVID-19 hospitalized patient.

It helps analyze patients' need for ICU facilities or ventilation and aids in the reduction of stress on healthcare resources. The test is a flow cytometry-based lymphocyte subset assay and is IVD-approved. Such innovations are anticipated to fuel industry growth in the near future. Moreover, flow cytometry is a significant tool in listing and characterizing immune cells, and is also helpful in recognizing and validating underlying genetic defects. The technique is also used to observe and monitor the immune response of patients after stem cell transplantation, and hence, organ transplantation plays an important role in boosting industry growth. According to the WHO, around 50,000 stem cell transplantations are performed globally every year, and this number is expected to grow in the near future, broadening the scope of applications for the technique.

On the other hand, instruments are highly expensive, and hence, buyers in several developing countries may not be able to afford technologically advanced flow cytometry equipment. These instruments may cost over USD 100,000 and pose significant budgetary constraints for small- & mid-sized hospitals and clinical laboratories. However, some manufacturers, such as Sony, are trying to launch newer instruments using software to automate a number of processes. Such developments would not only improve the usability of the technique but also help bring down the average instrumentation cost-under USD 100,000-in the near future.

Flow Cytometry Market Report Highlights:

• The instrument segment led the market with the largest revenue share of 35.30% in 2024 with owing to higher penetration driven by technological developments.
• Based on technology, the cell-based segment led the market with the largest revenue share of 76.16% in 2024.
• Based on application, the clinical segment led the market with the largest revenue share of 45.34% in 2024.
• Based on end use, the academic institutes segment accounted for the largest revenue share in 2024, driven by the extensive use of flow cytometry in cell biology and molecular diagnostics.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Market Definitions
• 1.3. Research Methodology
  • 1.3.1. Information Procurement
  • 1.3.2. Information or Data Analysis
  • 1.3.3. Market Formulation & Data Visualization
  • 1.3.4. Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Flow Cytometry Market Variables, Trends, & Scope

• 3.1. Market Introduction/Lineage Outlook
• 3.2. Market Size and Growth Prospects (USD Million)
• 3.3. Market Dynamics
  • 3.3.1. Market Drivers Analysis
    • 3.3.1.1. Growing prevalence of chronic and infectious diseases
    • 3.3.1.2. High R&D investments in biotechnology, clinical, and life science research
    • 3.3.1.3. Technological advancements in flow cytometry instruments and reagents
    • 3.3.1.4. Increasing demand for point-of-care diagnostics
  • 3.3.2. Market Restraints Analysis
    • 3.3.2.1. High cost of instruments
• 3.4. Flow Cytometry Market Analysis Tools
  • 3.4.1. Porter's Analysis
    • 3.4.1.1. Bargaining power of the suppliers
    • 3.4.1.2. Bargaining power of the buyers
    • 3.4.1.3. Threats of substitution
    • 3.4.1.4. Threats from new entrants
    • 3.4.1.5. Competitive rivalry
  • 3.4.2. PESTEL Analysis
    • 3.4.2.1. Political landscape
    • 3.4.2.2. Economic and Social landscape
    • 3.4.2.3. Technological landscape
    • 3.4.2.4. Environmental landscape
    • 3.4.2.5. Legal landscape

Chapter 4. Flow Cytometry Market: Product Estimates & Trend Analysis

• 4.1. Flow Cytometry Market: Product Movement Analysis
• 4.2. Flow Cytometry Market: Product Movement Analysis, USD Million, 2024 & 2030
• 4.3. Instruments
  • 4.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.3.2. Cell Analyzers
    • 4.3.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.3.3. Cell Sorters
    • 4.3.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.4. Reagents & Consumables
  • 4.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.5. Software
  • 4.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.6. Accessories
  • 4.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.7. Services
  • 4.7.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Flow Cytometry Market: Technology Estimates & Trend Analysis

• 5.1. Flow Cytometry Market: Technology Movement Analysis
• 5.2. Flow Cytometry Market: Technology Movement Analysis, USD Million, 2024 & 2030
• 5.3. Cell-based
  • 5.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.4. Bead-based
  • 5.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Flow Cytometry Market: Application Estimates & Trend Analysis

• 6.1. Flow Cytometry Market: Application Movement Analysis
• 6.2. Flow Cytometry Market: Application Movement Analysis, USD Million, 2024 & 2030
• 6.3. Research
  • 6.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.2. Pharmaceutical
    • 6.3.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.2.2. Drug Discovery
      • 6.3.2.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.2.3. Drug In Vitro Toxicity
      • 6.3.2.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.2.4. Drug Stem Cell
      • 6.3.2.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.3. Drug Apoptosis
    • 6.3.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.4. Cell Sorting
    • 6.3.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.5. Cell Cycle Analysis
    • 6.3.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.6. Immunology
    • 6.3.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.7. Cell Viability
• 6.4. Industrial
  • 6.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.5. Clinical
  • 6.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.2. Cancer
    • 6.5.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.3. Organ Transplantation
    • 6.5.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.4. Immunodeficiency
    • 6.5.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.5. Hematology
    • 6.5.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.6. Autoimmune Disorders

Chapter 7. Flow Cytometry Market: End Use Estimates & Trend Analysis

• 7.1. Flow Cytometry Market: End Use Movement Analysis
• 7.2. Flow Cytometry Market: End Use Movement Analysis, USD Million, 2024 & 2030
• 7.3. Clinical Testing Labs
  • 7.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.4. Academic Institutes
  • 7.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.5. Commercial Organizations
  • 7.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.2. Biotechnology Companies
    • 7.5.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.3. Pharmaceutical Companies
    • 7.5.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.4. CROs
• 7.6. Hospitals
  • 7.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Flow Cytometry Market: Regional Estimates & Trend Analysis

• 8.1. Flow Cytometry Market Share, By Region, 2024 & 2030, USD Million
• 8.2. North America
  • 8.2.1. North America Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.2.2. U.S.
    • 8.2.2.1. U.S. Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.2.2.2. Country Dynamics
    • 8.2.2.3. Competitive Scenario
    • 8.2.2.4. Regulatory Scenario
  • 8.2.3. Canada
    • 8.2.3.1. Canada Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.2.3.2. Country Dynamics
    • 8.2.3.3. Competitive Scenario
    • 8.2.3.4. Regulatory Scenario
  • 8.2.4. Mexico
    • 8.2.4.1. Mexico Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.2.4.2. Country Dynamics
    • 8.2.4.3. Competitive Scenario
    • 8.2.4.4. Regulatory Scenario
• 8.3. Europe
  • 8.3.1. Europe Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.3.2. UK
    • 8.3.2.1. UK Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.2.2. Country Dynamics
    • 8.3.2.3. Competitive Scenario
    • 8.3.2.4. Regulatory Scenario
  • 8.3.3. Germany
    • 8.3.3.1. Germany Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.3.2. Country Dynamics
    • 8.3.3.3. Competitive Scenario
    • 8.3.3.4. Regulatory Scenario
  • 8.3.4. France
    • 8.3.4.1. France Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.4.2. Country Dynamics
    • 8.3.4.3. Competitive Scenario
    • 8.3.4.4. Regulatory Scenario
  • 8.3.5. Italy
    • 8.3.5.1. Italy Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.5.2. Country Dynamics
    • 8.3.5.3. Competitive Scenario
    • 8.3.5.4. Regulatory Scenario
  • 8.3.6. Spain
    • 8.3.6.1. Spain Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.6.2. Country Dynamics
    • 8.3.6.3. Competitive Scenario
    • 8.3.6.4. Regulatory Scenario
  • 8.3.7. Denmark
    • 8.3.7.1. Denmark Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.7.2. Country Dynamics
    • 8.3.7.3. Competitive Scenario
    • 8.3.7.4. Regulatory Scenario
  • 8.3.8. Sweden
    • 8.3.8.1. Sweden Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.8.2. Country Dynamics
    • 8.3.8.3. Competitive Scenario
    • 8.3.8.4. Regulatory Scenario
  • 8.3.9. Norway
    • 8.3.9.1. Norway Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.9.2. Country Dynamics
    • 8.3.9.3. Competitive Scenario
    • 8.3.9.4. Regulatory Scenario
• 8.4. Asia Pacific
  • 8.4.1. Asia Pacific Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.2. Japan
    • 8.4.2.1. Japan Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.2.2. Country Dynamics
    • 8.4.2.3. Competitive Scenario
    • 8.4.2.4. Regulatory Scenario
  • 8.4.3. China
    • 8.4.3.1. China Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.3.2. Country Dynamics
    • 8.4.3.3. Competitive Scenario
    • 8.4.3.4. Regulatory Scenario
  • 8.4.4. India
    • 8.4.4.1. India Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.4.2. Country Dynamics
    • 8.4.4.3. Competitive Scenario
    • 8.4.4.4. Regulatory Scenario
  • 8.4.5. Australia
    • 8.4.5.1. Australia Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.5.2. Country Dynamics
    • 8.4.5.3. Competitive Scenario
    • 8.4.5.4. Regulatory Scenario
  • 8.4.6. South Korea
    • 8.4.6.1. South Korea Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.6.2. Country Dynamics
    • 8.4.6.3. Competitive Scenario
    • 8.4.6.4. Regulatory Scenario
  • 8.4.7. Thailand
    • 8.4.7.1. Thailand Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.7.2. Country Dynamics
    • 8.4.7.3. Competitive Scenario
    • 8.4.7.4. Regulatory Scenario
• 8.5. Latin America
  • 8.5.1. Latin America Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.2. Brazil
    • 8.5.2.1. Brazil Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.2.2. Country Dynamics
    • 8.5.2.3. Competitive Scenario
    • 8.5.2.4. Regulatory Scenario
  • 8.5.3. Argentina
    • 8.5.3.1. Argentina Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.3.2. Country Dynamics
    • 8.5.3.3. Competitive Scenario
    • 8.5.3.4. Regulatory Scenario
• 8.6. Middle East and Africa
  • 8.6.1. Middle East and Africa Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.2. South Africa
    • 8.6.2.1. South Africa Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.2.2. Country Dynamics
    • 8.6.2.3. Competitive Scenario
    • 8.6.2.4. Regulatory Scenario
  • 8.6.3. Saudi Arabia
    • 8.6.3.1. South Africa Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.3.2. Country Dynamics
    • 8.6.3.3. Competitive Scenario
    • 8.6.3.4. Regulatory Scenario
  • 8.6.4. UAE
    • 8.6.4.1. UAE Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.4.2. Country Dynamics
    • 8.6.4.3. Competitive Scenario
    • 8.6.4.4. Regulatory Scenario
  • 8.6.5. Kuwait
    • 8.6.5.1. Kuwait Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.5.2. Country Dynamics
    • 8.6.5.3. Competitive Scenario
    • 8.6.5.4. Regulatory Scenario

Chapter 9. Competitive Landscape

• 9.1. Recent Developments & Impact Analysis by Key Market Participants
• 9.2. Company Categorization
• 9.3. Company Heat Map Analysis
• 9.4. Company Profiles
  • 9.4.1. Danaher
    • 9.4.1.1. Participant's Overview
    • 9.4.1.2. Financial Performance
    • 9.4.1.3. Product Benchmarking
    • 9.4.1.4. Recent Developments/ Strategic Initiatives
  • 9.4.2. BD
    • 9.4.2.1. Participant's Overview
    • 9.4.2.2. Financial Performance
    • 9.4.2.3. Product Benchmarking
    • 9.4.2.4. Recent Developments/ Strategic Initiatives
  • 9.4.3. Sysmex Corporation
    • 9.4.3.1. Participant's Overview
    • 9.4.3.2. Financial Performance
    • 9.4.3.3. Product Benchmarking
    • 9.4.3.4. Recent Developments/ Strategic Initiatives
  • 9.4.4. Apogee Flow Systems Ltd.
    • 9.4.4.1. Participant's Overview
    • 9.4.4.2. Financial Performance
    • 9.4.4.3. Product Benchmarking
    • 9.4.4.4. Recent Developments/ Strategic Initiatives
  • 9.4.5. Bio-Rad Laboratories, Inc.
    • 9.4.5.1. Participant's Overview
    • 9.4.5.2. Financial Performance
    • 9.4.5.3. Product Benchmarking
    • 9.4.5.4. Recent Developments/ Strategic Initiatives
  • 9.4.6. Thermo Fisher Scientific, Inc.
    • 9.4.6.1. Participant's Overview
    • 9.4.6.2. Financial Performance
    • 9.4.6.3. Product Benchmarking
    • 9.4.6.4. Recent Developments/ Strategic Initiatives
  • 9.4.7. Stratedigm, Inc.
    • 9.4.7.1. Participant's Overview
    • 9.4.7.2. Financial Performance
    • 9.4.7.3. Product Benchmarking
    • 9.4.7.4. Recent Developments/ Strategic Initiatives
  • 9.4.8. Miltenyi Biotec
    • 9.4.8.1. Participant's Overview
    • 9.4.8.2. Financial Performance
    • 9.4.8.3. Product Benchmarking
    • 9.4.8.4. Recent Developments/ Strategic Initiatives
  • 9.4.9. Cytek Biosciences
    • 9.4.9.1. Participant's Overview
    • 9.4.9.2. Financial Performance
    • 9.4.9.3. Product Benchmarking
    • 9.4.9.4. Recent Developments/ Strategic Initiatives
  • 9.4.10. Sony Group Corporation (Sony Biotechnology Inc.)
    • 9.4.10.1. Participant's Overview
    • 9.4.10.2. Financial Performance
    • 9.4.10.3. Product Benchmarking
    • 9.4.10.4. Recent Developments/ Strategic Initiatives